MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Novo Nordisk

  • Ozempic’s Sister Drug Reduces Cardiovascular Risk by 14 Percent in Large-Scale Trial
    Ozempic’s Sister Drug Reduces Cardiovascular Risk by 14 Percent in Large-Scale Trial
    Learn about the study's possible impact on treatment strategies.
    October 21, 2024BY George Citroner
  • Microsoft Hit With EU Antitrust Charge, Risks Hefty Fine; Tesla Recalls Cybertrucks | Business Matters Full Broadcast (June 25)
    Microsoft Hit With EU Antitrust Charge, Risks Hefty Fine; Tesla Recalls Cybertrucks | Business Matters Full Broadcast (June 25)
    Microsoft is in trouble with the EU over its popular collaboration app Teams, and could face a large ...
    June 25, 2024BY Don Ma
  • Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
    Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
    The company said it conducted tests on compounded drugs that claim to contain semaglutide and found 'concerning levels ...
    December 1, 2023BY Lorenz Duchamps
  • FDA Found Bacterial Contamination at Novo Nordisk Diabetes Pill Manufacturing Facility
    FDA Found Bacterial Contamination at Novo Nordisk Diabetes Pill Manufacturing Facility
    The contamination does not affect its popular weight loss drugs Wegovy and Ozempic, according to the company.
    September 26, 2023BY Naveen Athrappully
  • Weight-Loss Jab Wegovy Available for the First Time on NHS
    Weight-Loss Jab Wegovy Available for the First Time on NHS
    A limited supply of the loss jab drug Wegovy has become available to patients via NHS specialists in ...
    September 4, 2023BY Owen Evans
  • Thyroid Cancer Concerns Raised Regarding Active Ingredient in Popular Drugs Ozempic and Wegovy
    Thyroid Cancer Concerns Raised Regarding Active Ingredient in Popular Drugs Ozempic and Wegovy
    The European Medicines Agency (EMA) has issued a drug safety signal (pdf) regarding the potential risk of thyroid ...
    June 24, 2023BY Harry Lee
  • Thousands of Australians Face Skyrocketing Costs as Labor Price Cut Force Lifesaving Drug From PBS
    Thousands of Australians Face Skyrocketing Costs as Labor Price Cut Force Lifesaving Drug From PBS
    The federal government is under pressure from the Coalition after removing a key lifesaving drug from the pharmaceutical ...
    March 13, 2023BY Victoria Kelly-Clark
TOP NEWS
  • US Air Force Responds to Suspected Drone Activity at UK Airbase
    NEW By Aldgra Fredly
    US Air Force Responds to Suspected Drone Activity at UK Airbase
  • SpaceX Sends 2nd Starship Into Orbit, Aborts Booster Catch at Launchpad
    2hr By T.J. Muscaro
    SpaceX Sends 2nd Starship Into Orbit, Aborts Booster Catch at Launchpad
  • Jensen Huang Scandal Puts Spotlight on National Security Concerns Over Nvidia’s AI Chips
    3hr By Andrew Moran
    Jensen Huang Scandal Puts Spotlight on National Security Concerns Over Nvidia’s AI Chips
  • Flávio Bolsonaro on His Escape, the Election, and His Plans for a Comeback
    4hr By Jan Jekielek, Epoch TV
    Flávio Bolsonaro on His Escape, the Election, and His Plans for a Comeback
  • Victims Describe the Moment Their Brooklyn Building Collapsed
    4hr By Nicholas Zifcak, Epoch Times
    Victims Describe the Moment Their Brooklyn Building Collapsed
  • Trump to Meet Putin, Xi on Sidelines of APEC Next Week, Officials Say
    4hr By Troy Myers
    Trump to Meet Putin, Xi on Sidelines of APEC Next Week, Officials Say
  • Van Hollen Makes His Case to Replace Schumer as Jeffries Is Heckled at Democratic Gathering
    5hr By Chase Smith
    Van Hollen Makes His Case to Replace Schumer as Jeffries Is Heckled at Democratic Gathering
  • Nvidia Shares Fall for a 2nd Day in Fallout From CEO Resignation
    5hr By Bill Pan
    Nvidia Shares Fall for a 2nd Day in Fallout From CEO Resignation
  • Tanker Collides With Docked Riverboat in New Orleans
    6hr By Jacki Thrapp
    Tanker Collides With Docked Riverboat in New Orleans
  • Nationwide Ground Stop Lifted After More Than 5 Hours
    7hr By Jill McLaughlin
    Nationwide Ground Stop Lifted After More Than 5 Hours
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top